Synthetic Ribozymes: The Hammerhead Ribozyme

Concepts in Gene Therapy

Volumn , Issue , 2020, Pages 169-195

  Heidenreich, Olaf ^a   Eckstein, Fritz ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85134279154     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1515/9783110808636-011     Document Type: Chapter

References (96)

1. Eckstein, F. and Lilley, D. M. J. (eds.). (1996). RNA catalysis. Nucleic Acids and Molecular Biology, vol. 10. Heidelberg: Springer.
2. Bratty, J., Chartrand, P., Ferbeyre, G., and Cedergren, R. (1993). The hammerhead RNA domain, a model ribozyme. Biochim. Biophys. Acta. 1216, 345-359.
3. Birikh, K. R., Heaton, P. A. and Eckstein, F. (1997). The structure, function and application of the hammerhead ribozyme. Eur. J. Biochem. 245, 1-16.
4. Sczakiel, G. and Nedbal, W. (1995). The potential of ribozymes as antiviral agents. Trends Microbiol. 3, 213-217.
5. Whitton, J. L. (1994). Antisense treatment of viral infection. Adv. Virus Res. 44, 267-303.
6. Kiehntopf, M., Esquivel, E. L., Brach, M. A., and Herrmann, F. (1995). Clinical applications of ribozymes. Lancet. 345, 1027-1031.
7. Buzayan, J. M., Gerlauch, W. L., and Bruening, G. (1986). Non-enzymatic cleavage and ligation of RNAs complementary to a plant virus satellite RNA. Nature. 323, 349-353.
8. Prody, G. A., Bakos, J. T., Buzayan, J. M., Schneider, I. R., and Bruening, G. (1986). Autolytic processing of dimeric plant virus satellite RNA. Science. 231, 1577-1580.
9. Forster, A. C. and Symons, R. H. (1987). Self-cleavage of plus and minus RNAs of a virusoid and a structural model for the active site. Cell. 49, 211-220.
10. Epstein, L. M. and Gall, J. G. (1987). Self-cleaving transcripts of satellite DNA from the newt. Cell. 48, 535-543.
11. Bruening, G. (1989). Compilation of self-cleaving sequences from plant virus satellite RNAs and other sources. Methods Enzymol. 180, 546-558.
12. Ruffner, D. E., Stormo, G. D., and Uhlenbeck, O. C. (1990). Sequence requirements of the hammerhead RNA self-cleavage reaction. Biochemistry. 29, 10695-10702.
13. Pley, H. W., Flaherty, K. M., and McKay, D. B. (1994). Three-dimensional structure of a hammerhead ribozyme. Nature. 372, 68-74.
14. Scott, W. G., Finch, J. T., and Klug, A. (1995). The crystal structure of an all-RNA hammerhead ribozyme: a proposed mechanism for RNA catalytic cleavage. Cell. 81, 991-1002.
15. Tuschl, T., Gohlke, C., Jovin, T. M., Westhof, E., and Eckstein, F. (1994). A three-dimensional model for the hammerhead ribozyme based on fluorescence measurements. Science. 266, 785-789.
16. Bassi, G. S., Møllegard, N.-E., Murchie, A. I. H., von Kitzing, E., and Lilley, D. M. J. (1995). Ionic interactions and the global conformations of the hammerhead ribozyme. Nature Struct. Biol. 2, 45-55.
17. Tuschl, T. and Eckstein, F. (1993). Hammerhead ribozymes: Importance of stem-loop II for activity. Proc. Natl. Acad. Sci. USA. 90, 6991-6994.
18. Symons, R. H. (1992). Small catalytic RNAs. Annu. Rev. Biochem. 61, 641-671.
19. Eckstein, F. (1985). Nucleoside phosphorothioates. Annu. Rev. Biochem. 54, 367-402.
20. van Tol, H., Buzayan, J. M., Feldstein, P. A., Eckstein, F., and Bruening, G. (1990). Two autolytic processing reactions of a satellite RNA proceed with inversion of configuration. Nucleic Acids Res. 18, 1971-1975.
21. Slim, G. and Gait, M. J. (1991). Configurationally defined phosphorothioate-containing oligoribonucleotides in the study of the mechanism of cleavage of hammerhead ribozymes. Nucleic Acids Res. 19, 1183-1188.
22. Dahm, S. C. and Uhlenbeck, O. C. (1991). Role of divalent metal ions in the hammerhead RNA cleavage reaction. Biochemistry. 30, 9464-9469.
23. Dahm, S. C., Derrick, W. B., and Uhlenbeck, O. C. (1993). Evidence for the role of solvated metal hydroxide in the hammerhead cleavage mechanism. Biochemistry. 32, 13040-13045.
24. Haseloff, J. and Gerlach, W. L. (1988). Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature. 334, 585-591.
25. Hertel, K. J., Herschlag, D., and Uhlenbeck, O. C. (1994). A kinetic and thermodynamic framework for the hammerhead ribozyme reaction. Biochemistry. 33, 3374-3385.
26. Porschke, D. and Eigen, M. (1971). Co-operative non-enzymic base recognition. J. Mol. Biol. 62, 361-381.
27. Uhlenbeck, O. C. (1987). A small catalytic oligoribonucleotide. Nature. 328, 596-600.
28. Hoffman, L. M. and Johnson, M. G. (1994). Enzymatic synthesis of milligram quantities of ribozymes in small volumes. Biotechniques. 17, 372-375.
29. Moore, M. J. and Sharp, P. A. (1992). Site -specific modification of pre-mRNA: The 2'-hydroxyl groups at the splice sites. Science 256, 992-997.
30. Eaton, B. E. and Pieken, W. A. P. (1995). Ribonucleosides and RNA. Ann. Rev. Biochem. 64, 837-863.
31. Aurup, H., Williams, D. M., and Eckstein, F. (1991). 2'-Fluoro- and 2'-amino-2'-deoxynucleoside-5'-triphosphates as substrates for T7 RNA ppolymerase. Biochemistry. 31, 9636-9643.
32. Wincott, F., DiRenzo, A., Shaffer, C., Grimm, S., Tracz, D., Workman, C., Sweedler, D., Gonzalez, C., Scaringe, S., and Usman, N. (1995). Synthesis, deprotection, analysis and purification of RNA and ribozymes. Nucleic Acids Res. 23, 2677-2684.
33. Ogilvie, K. K., Usman, N., Nicoghosian, K., and Cedergren, R. J. (1988). Total chemical synthesis of a 77 nucleotide long RNA sequence having methionine-acceptance activity. Proc. Natl. Acad. Sci. USA. 85, 5764-5768.
34. Gait, M. J., Pritchard, C., and Slim, G. (1991). Oligoribonucleotide synthesis. In: Oligonucleotides and analogues: A practical approach. Eckstein ed. Oxford: Oxford University Press, 25-48.
35. Heidenreich, O., Benseler, F., Fahrenholz, A., and Eckstein, F. (1994). High activity and stability of hammerhead ribozymes containing 2'-modified pyrimidine nucleosides and phosphorothioates. J. Biol. Chem. 269, 2131-2138.
36. Beigelman, L., McSwiggen, J. A., Draper, K. G., Gonzalez, C., Jensen, K., Karpeisky, A. M., Modak, A. S., Matulic-Adamic, J., DiRenzo, A. B., Haeberli, P., S. D., Tracz, D., Grimm, S., Wincott, F. E., Thackray, V. G., and Usman, N. (1995). Chemical modification of hammerhead ribozymes. J. Biol. Chem. 270, 25702-25708.
37. Fersht, A. (1985). Enzyme structure and mechanism. New York: Freeman.
38. L’Huillier, P. J., Davis, S. R., and Bellamy, A. R. (1992). Cytoplasmic delivery of ribozymes leads to efficient reduction in a-lactalbumin mRNA levels in C127I mouse cells. EMBO J. 11, 4411-4418.
39. Bertrand, E., Pictet, R., and Grange, T. (1994). Can hammerhead ribozymes be efficient tools to inactivate gene function? Nucleic Acids Res. 22, 293-300.
40. Heidenreich, O., Kang, S.-H., Brown, D. A., Xu, X., Swiderski, P., Rossi, J. J., Eckstein, F., and Nerenberg, M. (1995). Ribozyme-mediated RNA degradation in nuclei suspension. Nucleic Acids Res. 23, 2223-2228.
41. Heidenreich, O. and Eckstein, F. (1992). Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1. J. Biol. Chem. 267, 1904-1909.
42. Crisell, P., Thompson, S., and James, W. (1993). Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro. Nucleic Acids Res. 21, 5251-5255.
43. Denman, R. B. (1993). Using RNAFOLD to predict the activity of small catalytic RNAs. Biotechniques. 15, 1090-1094.
44. Kobayashi, H., Kim, N., Halatsch, M.-E., and Ohnuma, T. (1994). Specificity of ribozyme designed for mutated DHFR mRNA. Biochem. Pharmacol. 47, 1607-1613.
45. Herschlag, D. (1991). Implications of ribozyme kinetics for targeting the cleavage of specific RNA molecules in vivo: More isn’t always better. Proc. Natl. Acad. Sci. USA. 88, 6921-6925.
46. Werner, M. and Uhlenbeck, O. C. (1995). The effect of base mismatches in the substrate recognition helices of hammerhead ribozymes on binding and catalysis. Nucleic Acids Res. 23, 2092-2096.
47. Zoumadakis, M., Neubert, W. J., and Tabler, M. (1994). The influence of imperfectly paired helices I and III on the catalytic of hammerhead ribozymes. Nucleic Acids Res. 22, 5271-5278.
48. Sczakiel, G. (1994). Antisense strategies for the control of aberrant gene expression. J. Hematother. 3, 305-313.
49. Xing, Z. and Whitton, J. L. (1992). Ribozymes which cleave arenavirus RNAs: Identification of susceptible target sites and inhibition by target site secondary structure. J. Virol. 66, 1361-1369.
50. Sczakiel, G., Homann, M., and Rittner, K. (1993). Computer-aided search for effective antisense RNA target sequences of the human immunodeficiency virus type 1. Antisense Res. Dev. 3, 45-52.
51. Christoffersen, R. E., McSwiggen, J., and Konings, D. (1994). Application of computational technologies to ribozyme biotechnology products. Theochem. J. Mol. Struct. 311, 273-284.
52. Rittner, K., Burmester, C., and Sczakiel, G. (1993). In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1. Nucleic Acids Res. 21, 1381-1387.
53. Lieber, A. and Strauss, M. (1995). Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library. Mol. Cell. Biol. 15, 540-551.
54. Campbell, T. B. and Cech, T. R. (1995). Identification of ribozymes within a ribozyme library that efficiently cleave a long substrate RNA. RNA. 1, 598-609.
55. Cotten, M., Schaffner, G., and Birnstiel, M. L. (1989). Ribozyme, antisense RNA, and antisense DNA inhibition of U7 small nuclear ribonucleoprotein-mediated histone pre-mRNA processing in vitro. Mol. Cell. Biol. 9, 4479-4487.
56. Denman, R. B., Purow, B., Rubenstein, R., and Miller, D. L. (1992). Hammerhead ribozyme cleavage of hamster prion pre-mRNA in complex cell-free model systems. Bichem. Biophys. Res. Comm. 186, 1171-1177.
57. Tsuchihashi, Z., Khosla, M., and Herschlag, D. (1993). Protein enhancement of hammerhead ribozyme catalysis. Science. 262, 99-102.
58. Bertrand, E. L. and Rossi, J. J. (1994). Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear protein AI. EMBO J. 13, 2904-2912.
59. Herschlag, D., Khosla, M., Tsuchihashi, Z., and Karpel, R. L. (1994). An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis. EMBO J. 13, 2913-2924.
60. Müller, G., Strack, B., Dannull, J., Sproat, B. S., Surovoy, A., Jung, G., and Moelling, K. (1994). Amino acid requirements of the nucleocapsid protein of HIV-1 for increasing catalytic activity of a Ki-ras ribozyme in vitro. J. Mol. Biol. 242, 422-429.
61. Herschlag, D. (1995). RNA chaperones and the RNA folding problem. J. Biol. Chem. 270, 20871-20874.
62. Sioud, M. (1994). Interaction between tumour necrosis factor a ribozyme and cellular proteins. J. Mol. Biol. 242, 619-629.
63. Stein, C. A. and Cheng, Y.-C. (1993). Antisense oligonucleotides as therapeutic agents - Is the bullet really magical? Science. 261, 1004-1012.
64. Sullenger, B. A. and Cech, T. R. (1993). Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA. Science. 262, 1566-1569.
65. Heidenreich, O., Pieken, W., and Eckstein, F. (1993). Chemically modified RNA: approaches and applications. FASEB J. 7, 90-96.
66. Heidenreich, O., Kang, S.-H., Xu, X., and Nerenberg, M. (1995). Application of antisense technology to therapeutics. Mol. Medicine Today. 1, 128-133.
67. Shimayama, T., Nishikawa, F., Nishikawa, S., and Taira, K. (1993). Nuclease-resistant chimeric ribozymes containing deoxyribonucleotides and phosphorothioate linkages. Nucleic Acids Res. 21, 2605-2611.
68. Heidenreich, O., Xu, X., Swiderski, P., Rossi, J. J., and Nerenberg, M. (1996). Correlation of activity with stability of chemically modified ribozymes in nuclei suspension. Antisense and Nucleic Acid Drug Devel. 6, 111-118.
69. Ruffner, D. E. and Uhlenbeck, O. C. (1990). Thiophosphate interference experiments locate phosphates important for the hammerhead RNA self-cleavage reaction. Nucleic Acids Res. 18, 6025-6029.
70. Guschlbauer, W. and Jankowski, K. (1980). Nucleic Acids Res. 8, 1421-1433.
71. Saenger, W. (1984). Principles of nucleic acid structure. Heidelberg: Springer.
72. Aurup, H., Tuschl, T., Benseier, F., Ludwig, J., and Eckstein, F. (1994). Oligonucleotide duplexes containing 2'-amino-2'-deoxycytidines: thermal stability and chemical reactivity. Nucleic Acids Res. 22, 20-24.
73. Monia, B. P., Lesnik, E. A., Gonzalez, C., Lima, W. F., McGee, D., Guinosso, C. J., Kawasaki, A. M., Cook, P. D., and Freier, S. M. (1993). Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 268, 14514-14522.
74. Yang, J.-H., Usman, N., Chartrand, P., and Cedergren, R. (1992). Minimum ribonucleotide requirement for catalysis by the RNA hammerhead domain. Biochemistry. 31, 5005-5009.
75. Paolella, G., Sproat, B. S., and Lamond, A. I. (1992). Nuclease resistant ribozymes with high catalytic activity. EMBO J. 11, 1913-1919.
76. Pieken, W. A., O. D. B., Benseler, F., Aurup, H., and Eckstein, F. (1991). Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes. Science. 253, 314-317.
77. Lange, W., Cantin, E. M., Finke, J., and Dolken, G. (1993). In vitro and in vivo effects of synthetic ribozymes targeted against BCR/ABL mRNA. Leukemia. 7, 1786-1794.
78. Snyder, D. S., Wu, Y., Wang, J. L., Rossi, J. J., Swiderski, P., Kaplan, B. E., and Forman, S. J. (1993). Ribozyme-mediated Inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line. Blood. 82, 600-605.
79. Zabner, J., Fasbender, A. J., Moninger, T., Poellinger, K. A., and Welsh, M. J. (1995). Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270, 18997-19007.
80. Wagner, E., Zatloukal, K., Cotten, M., Kirlappos, H., Mechtler, K., Curiel, D. T., and Bimstiel, M. (1992). Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. USA. 89, 6099-6103.
81. Plank, C., Oberhauser, B., Mechtler, K., Koch, C., and Wagner, E. (1994). The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. 269, 12918-12924.
82. Zelphati, O., Imbach, J.-L., Signoret, N., Zon, G., Rayner, B., and Leserman, L. (1994). Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms. Nucleic Acids Res. 22, 4307-4314.
83. Romani, A. and Scarpa, A. (1992). Regulation of cell magnesium. Arch. Biochem. Biophys. 298, 1-12.
84. Beck, J. and Nassal, M. (1995). Efficient hammerhead ribozyme-mediated cleavage of the structured hepatitis B virus encapsidation signal in vitro and in cell extracts, but not in intact cells. Nucleic Acids Res. 23, 4954-4962.
85. Heidenreich, O., Xu, X., and Nerenberg, M. (1996). A hammerhead ribozyme cleaves its target RNA during RNA preparation. Antisense and Nucleic Acid Drug Devel. 6, 141-144.
86. Sioud, M., Natvig, J. B., and Førre, Ø. (1992). Preformed ribozyme destroys tumour necrosis factor mRNA in human cells. J. Mol. Biol. 223, 831-835.
87. Lange, W., Daskalatis, M., Finke, J., and Dolken, G. (1994). Comparison of different ribozymes for efficient and specific cleavage of BCR/ABL related mRNAs. FEBS Lett. 338, 175-178.
88. Leopold, L. H., Shore, S. K., Newkirk, T. A., Reddy, R. M. V., and Reddy, E. P. (1995). Multi-unit ribozyme-mediated cleavage of bcr-abl mRNA in myeloid leukemias. Blood. 85, 2162.
89. Kiehntopf, M., Brach, M. A., Licht, T., Petschauer, S., Karawajew, L., Kirschning, C., and Herrmann, F. (1994). Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells. EMBO J. 13, 4645-4652.
90. Kiehntopf, M., Herrmann, F., and Brach, M. A. (1995). Functional NF-IL6/CCAAT enhancerbinding protein is required for tumor necrosis factor a-inducible expression of the granulocyte colony-stimulating factor (CSF), but not the granulocyte/macrophage CSF or interleukin 6 gene in human fibroblasts. J. Exp. Med. 181, 793-798.
91. Tanaka, T., Akira, S., Yoshida, K., Umemoto, M., Yoneda, Y., Shirafuji, N., Fujiwara, H., Suematsu, S., Yoshida, N., and Kishimoto, T. (1995). Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell. 80, 353-361.
92. Gu, J.-L., Veerapanane, D., Rossi, J., Natarajan, R., Thomas, L., and Nadler, J. (1995). Ribozymemediated inhibition of expression of leukocyte-type 12-lipoxygenase in porcine aortic vascular smooth muscle cells. Circ. Res. 77, 14-20.
93. Homann, M., Tzortzakaki, S., Rittner, K., Sczakiel, G., and Tabler, M. (1993). Incorporation of the catalytic domain of a hammerhead ribozyme into antisense RNA enhances its inhibitory effect on the replication of human immunodeficiency virus type 1. Nucleic Acids Res. 21, 2809-2814.
94. Sczakiel, G. and Goody, R. S. (1994). Antisense principle or ribozyme action? Biol. Chem. Hoppe-Seyler. 375, 745-746.
95. Lyngstradaas, S. P., Risnes, S., Sproat, B. S., Thrane, P. S., and Prydz, H. P. (1995). A synthetic, chemically modified ribozyme eliminates amelogenin, the major translation product in developing mouse enamel in vivo. EMBO J. 14, 5224-5229.
96. Hertel, K. J., Pardi, A., Uhlenbeck, O. C., Koizumi, M., Ohtsuka, E., Uesugi, S., Cedergren, R., Eckstein, F., Gerlach, W. L., Hodgson, R., and Symons, R. H. (1992). Numbering system for the hammerhead. Nucleic Acids Res. 20, 3252.